Asymmetrex Starts New Campaign for Greater Awareness of the Importance of Counting Tissue Stem Cells
Now that Massachusetts stem cell biotechnology company Asymmetrex has developed the first and only technology for specific and accurate counting of therapeutic tissue stem cells, today the company has launched a campaign to alert stem cell scientists, physicians, and patients to the long unmet need of a means to count tissue stem cells. The major